TT Capital Partners and Global Health Innovation Fund, an evergreen vehicle managed by biopharmaceutical company Merck Sharp & Dohme (MSD), have made a growth capital investment in UK-based healthcare and life sciences software business Clinithink.
Renaud Tourmente will join as partner and be part of Capzanine's executive committee
Hitzinger was undergoing self-administration before the consortium acquired the company
Graftys sells products in 25 countries and plans to penetrate new markets with the funding
US pension has targeted $80m for new private markets commitments through the rest of 2019